Comparison of DisCoVisc and Hydroxypropylmethylcellulose 2%

University of Sao Paulo39 enrolled

Overview

This prospective study was performed to compare two ophthalmic viscosurgical devices, DisCoVisc (hyaluronic acid 1.6% - chondroitin sulfate 4.0%) and hydroxypropylmethylcellulose 2% in terms of their overall clinical performance during phacoemulsification.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

Conditions

Corneal Edema Intraocular Pressure

Interventions

Hyaluronic Acid and hydroxypropylmethylcelluloseDRUG

Hyaluronic Acid 1.6% was used to performed phacoemulsification in one eye and hydroxypropylmethylcellulose 2% was used in the fellow eye.

Eligibility

Sex: ALLMin age: 50 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Bilateral age-related cataract * Grade 1-3 lens opacities classification system (LOCS III) * Pupil dilatation greater than 7.0 mm Exclusion Criteria: * Black, brunescent, traumatic or subluxated cataract * Corneal endothelial disease (endothelial cell count less than 2.000 cells/mm3) * Glaucoma, uveitis * Previous ocular surgery

Locations (1)

University of São Paulo

São Paulo, São Paulo, Brazil

Outcomes

Primary Outcomes

Corneal endothelial cell count

Time frame: 6 months

Secondary Outcomes

Central Corneal Thickness

Time frame: 7 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.